CLVSF (CellaVision AB) Net Issuance of Preferred Stock : $0.00 Mil (TTM As of Mar. 2025)

View and export this data going back to 2010. Start your Free Trial

What is CellaVision AB Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

CellaVision AB's net issuance of preferred for the three months ended in Mar. 2025 was $0.00 Mil. The number is 0, which means that CellaVision AB has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

CellaVision AB's net issuance of preferred for the trailing twelve months (TTM) ended in Mar. 2025 was $0.00 Mil.

CellaVision AB Net Issuance of Preferred Stock Historical Data

The historical data trend for CellaVision AB's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellaVision AB Net Issuance of Preferred Stock Chart

CellaVision AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Issuance of Preferred Stock

Get a 7-Day Free Trial

CellaVision AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Issuance of Preferred Stock	Get a 7-Day Free Trial															-	-	-	-	-

CellaVision AB Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

CellaVision AB Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of CellaVision AB's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

CellaVision AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CellaVision AB (OTCPK:CLVSF) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

CEVI:Sweden 0MR5:UK CEVIs:UK C26:Germany C26:Germany

Address

Mobilvagen 12, Lund, SWE, 22362

Website

https://www.cellavision.com

CellaVision AB is engaged in the business of supplying digital solutions for blood and body fluid analysis. Its solutions are based on digital image analysis technology, artificial intelligence, and information technology. The firm's product portfolio consists of CellaVision peripheral blood application, CellaVision advanced RBC application, and CellaVision remote review software. Its customers include mainly large hospital laboratories and commercial laboratories in North America, Europe and China, and Japan. The company derives the majority of its revenue from the sale of analyzers or software.